These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis. Edwards R; Greenwood D J Antimicrob Chemother; 1996 Dec; 38(6):941-51. PubMed ID: 9023641 [TBL] [Abstract][Full Text] [Related]
24. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci. Kitzis MD; Acar JF; Gutmann L J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204 [TBL] [Abstract][Full Text] [Related]
25. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials. Iaconis JP; Pitkin DH; Sheikh W; Nadler HL Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693 [TBL] [Abstract][Full Text] [Related]
26. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms]. Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400 [TBL] [Abstract][Full Text] [Related]
27. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. Jackson JJ; Kropp H J Infect Dis; 1992 Jun; 165(6):1033-41. PubMed ID: 1583320 [TBL] [Abstract][Full Text] [Related]
28. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa. Dib C; Trias J; Jarlier V Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):979-86. PubMed ID: 8654449 [TBL] [Abstract][Full Text] [Related]
29. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics]. Tsuji A Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080 [No Abstract] [Full Text] [Related]
30. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa. Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200 [TBL] [Abstract][Full Text] [Related]
31. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy. Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376 [TBL] [Abstract][Full Text] [Related]
32. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa. Hu YF; Liu CP; Wang NY; Shih SC BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962 [TBL] [Abstract][Full Text] [Related]
33. Resistance of Pseudomonas aeruginosa to cefsulodin: modification of penicillin-binding protein 3 and mapping of its chromosomal gene. Gotoh N; Nunomura K; Nishino T J Antimicrob Chemother; 1990 Apr; 25(4):513-23. PubMed ID: 2112536 [TBL] [Abstract][Full Text] [Related]
34. Characterization of multiresistant strains of Neisseria gonorrhoeae isolated in Nicaragua. Castro I; Bergeron MG; Chamberland S Sex Transm Dis; 1993; 20(6):314-20. PubMed ID: 8108753 [TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605 [TBL] [Abstract][Full Text] [Related]
37. Structure activity relationships in PIPC-analogues against Pseudomonas aeruginosa. Mitsuyama J; Hori R; Ito Y; Yotsuji A; Yasuda T; Saikawa I J Antibiot (Tokyo); 1989 Apr; 42(4):598-603. PubMed ID: 2498272 [TBL] [Abstract][Full Text] [Related]
38. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals. Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901 [TBL] [Abstract][Full Text] [Related]
39. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Quale J; Bratu S; Landman D; Heddurshetti R Clin Infect Dis; 2003 Jul; 37(2):214-20. PubMed ID: 12856214 [TBL] [Abstract][Full Text] [Related]
40. Effects of inner-membrane-associated beta-lactamase on penicillin-binding protein assays. Study of stably derepressed Pseudomonas aeruginosa strains from experimental endocarditis. Parr TR; Chan L; Bayer AS Chemotherapy; 1988; 34(6):478-83. PubMed ID: 3149570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]